, and these point to variation in cell mediated immunity as driving susceptibility. These genes also potentially point to specific pathogens.
There is empirical and epidemiological evidence that pathogens could be environmental triggers, but the distinction between association and causation is problematic. Two likely mechanisms for The strongest candidate to date is EBV, which fulfils all these criteria 6 . Although typically 90% of the general population carry EBV, virtually 100% of people with MS do. Notably, though, other common chronic viruses, such as HHV6, chicken pox, measles and cytomegalovirus have also been described as more prevalent in MS 7 ,
such that exposure to these viruses might also render people susceptible to MS and the virus is not causative but associative High EBV antibody titres, in combination with the first MS susceptibility gene, and variant of largest effect yet known, HLA DRB1*1501, increases the risk of MS, additively and independently, not interactively 13 . Oligoclonal bands found in the CSF of many with MS can be reactive to EBV and other herpesviruses 14 .
EBV infects B cells through CD21 6 , and possibly CD35 15 . Both of these genes are not among those known to affect susceptibility to MS. The infected B cells proliferate through signaling through EBVs own analogue of human CD40. Strikingly, genetic variants of CD40
are associated with MS, and the genotype with higher expression of CD40 decreases MS risk 16 . Because CD40 is a costimulatory molecule required for T cell activation, it would be expected that higher expression would increase the risk of MS. A potential explanation for this paradox is that low host CD40 expression on B cells favours proliferation/survival of EBV infected B cells, using their EBV CD40.
In support of this, anti-CD20 B-cell-depleting drugs such as Rituximab, which are used as a therapies to reduce EBV infection 17 
